Pricing Log in Create free account

Pharvaris N.V. (PHVS) vs Vera Therapeutics, Inc. (VERA)

Pharvaris N.V. and Vera Therapeutics, Inc. are both Biotechnology companies. Pharvaris N.V. and Vera Therapeutics, Inc. are of similar size ($2.1B and $2.1B). Across the 9 metrics below, Pharvaris N.V. leads on 8 and Vera Therapeutics, Inc. on 1.

Valuation

Metric PHVS VERA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 5.41 4.91 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (10.96%) (21.02%) (33.15%)
Free cash flow yield (9.41%) (16.92%) (25.50%)

Profitability

Metric PHVS VERA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (71.50%) (91.75%) (56.36%)
Return on assets (64.43%) (72.32%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PHVS VERA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (25.37%) (69.45%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHVS VERA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 11.94 10.92 4.72
Net debt to EBITDA 1.72 2.00 0.96

Dividend

Metric PHVS VERA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PHVS VERA Biotechnology median
Market cap 2.07b 2.06b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack